Mara Aspinall: The Former CEO Now Funding the Genomics Revolution

If you care about the future of genomics, diagnostics, and biotech investing, you can’t miss this episode.We’re joined by Mara Aspinall, Partner at Illumina Ventures, a trailblazer with over 30 years of leadership in diagnostics and eight years in venture capital funding groundbreaking genomics companies.In this episode, Mara reveals:The next wave of diagnostics, from liquid biopsies to home testing and new AI-driven tools.Hard-won lessons from leading Genzyme Genetics, Roche Tissue Diagnostics, and building her own startup.Insider tips for founders on pitching, choosing the right investors, and building winning teams.A glimpse into where genomics is heading in the next decade - from neurodegenerative disease detection to early metabolic disease diagnostics.With her unmatched experience as an operator, educator, and investor, Mara brings clarity, energy, and vision to a fast-changing field. This conversation is packed with takeaways for founders, investors, and anyone fascinated by the future of healthcare.🎧 Tune in now for a masterclass in diagnostics, genomics, and venture capital from one of the industry’s most influential voices.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentMara AspinallPartner At Illumina VenturesLinkedIn: https://www.linkedin.com/in/mara-aspinall-6688142/Lawrence RoseCo-Founder + Talent Solutions Director At ARTOLinkedIn: https://www.linkedin.com/in/lawrencerose/Timestamps:00:00 Career Beginnings04:10 Current Diagnostic Trends20:48 The Founder Investor Fit25:37 Genetics & Genomics29:06 Mara Aspinall39:31 Neurodegenerative Disease#LeadingBeyondTheLab #ARTOTalent #Biotechnology  Hosted on Acast. See acast.com/privacy for more information.